Skip to main content
CivixlyCivixly
HomeFederal GovernmentState GovernmentLearnCommunityFeedback
Sign InCreate Account
Menu
HomeFederal GovernmentState GovernmentLearnCommunityFeedback
Sign InCreate Account
Civixly

Find representatives, follow federal and state legislation, and connect public records to the people and institutions responsible for them.

Explore

Federal governmentState governmentCivics guides

About the data

About CivixlyMethodologyData sources

Help improve Civixly

Send feedback or a correctionCommunity

State Government / Delaware / Legislation / SB 262

SB 262Session 153SenateIn committee

AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT.

Kratom is an herb derived from a leafy Southeast Asia tree, known formally as Mitragyna speciosa. Kratom contains two psychoactive compounds, mitragynine and 7-hydroximitragynine. Both compounds can bind to opioid receptors in the brain and produce a pharmacological response similar to the effects of other opioids, such as morphine, and can lead to addiction. An estimated 11 to 15 million Americans consume Kratom regularly. According to a 2025 study by the Legislative Analysis and Public Policy Association, 24 states and the District of Columbia regulate kratom or its components in some manner. In six states (Alabama, Arkansas, Indiana, Rhode Island, Vermont, and Wisconsin) and the District of Columbia, kratom’s psychoactive components are considered controlled substances. In 18 states, the possession, sale, manufacture, etc. of kratom products is regulated. A Center for Disease Control analysis found that kratom was implicated in 846 fatal overdose cases across 30 states and the District of Columbia in 2022. Other reports suggest over 2,000 fatal overdoses have been linked to kratom since 2021. This Act amends Delaware’s Uniform Controlled Substances Act. The Act defines “Kratom” and “Kratom Products”. The Act makes it unlawful to manufacture, distribute, sell, offer to sell, or possess with intent to sell a Kratom Product. This Substitute differs from the original bill in that it fits kratom into the Uniform Controlled Substances Act by specifying tier quantities for drug offenses that result in the classification of the charge under the existing criminal framework. It moves to the definition of "kratom products" any product that contains the active ingredients of kratom, regardless of whether the product is represented, labeled, or marketed as “kratom” or not. It removes criminal charges for simple possession by an individual, and it clarifies that manufacturing, selling, or delivery of kratom or similar products is subject to criminal charges under this chapter.

Latest development · Apr 15, 2026

Adopted in lieu of the original bill SB 262, and Assigned to Health & Social Services Committee in Senate

Your view
Source record ↗
Session
153
Introduced
Apr 15, 2026
Latest passage
Date unavailable
TopicsSponsorsActionsDiscussion

Topics and classification

Civixly topics

Justice & Public Safety

Document type

Bill

Sponsors

Primary sponsors are listed before cosponsors and other sponsoring entities.

Primary sponsorKyra L. Hoffner

Action timeline

Newest action first. Action language is supplied by the state source.

View full action timeline1 action⌄
  1. Apr 15, 2026

    Adopted in lieu of the original bill SB 262, and Assigned to Health & Social Services Committee in Senate

    IntroductionReferral CommitteeSenate

SB 262 discussion

0 comments

Sign in to join the discussion.Comments are publicly visible.

Loading comments...

State legislative data provided by Open States and linked legislature sources when available.

Civixly tracks state bill actions, passage dates, and sponsors. Member-level state roll-call histories are not included.

Source data last updated Aug 26, 2026.